Tag: VEITHsymposium 2016
Animal experiments raise possibility of wireless vascular flow monitoring
Remote monitoring of bypass flow using an implantable piezoelectric sensor, which can also be placed on stents, has shown successful and reliable transmission of...
Automated planning software could lead to wider FEVAR adoption
While the long-term durability of fenestrated endovascular repair (FEVAR) has been established, the need for accurate procedural planning may act as a barrier to...
Mind over matter: EVAR under hypnosis
The use of hypnosis during endovascular aneurysm repair (EVAR) may improve haemodynamic and respiratory stability and allow faster patient recovery, according to a presentation...
VeClose trial indicates 24-month non-inferiority of VenaSeal versus radiofrequency ablation
Two-year outcomes of the VeClose pivotal trial have been reported, showing a 94.3% closure rate and “continued non-inferiority results to radiofrequency ablation” when using...
MOCA effective for greater saphenous vein insufficiency out to three years
A Dutch study of greater saphenous vein insufficiency patients has found that mechanochemical ablation (MOCA; ClariVein, Vascular Insights) is an effective and safe treatment...
“Non-fluoroscopic imaging and navigation will replace our current modalities for endovascular...
Due to its two-dimensional (2D) nature and the high radiation exposure associated with its use, fluoroscopy is an imperfect solution to endovascular surgery’s need...
Mind over matter: EVAR under hypnosis
The use of hypnosis during endovascular aneurysm repair (EVAR) may improve haemodynamic and respiratory stability and allow faster patient recovery, according to a presentation...
Comparison of EVAR 1 and ENGAGE data shows the evolution of...
The EVAR 1 trial—investigating the efficacy of endovascular aneurysm repair (EVAR) versus open repair—and the ENGAGE registry—examining the performance of the Endurant (Medtronic) stent...
Santi Trimatchi: The IRAD Registry
Santi Trimarchi, University of Milan, Policlinico San Donato IRCCS, Milan, Italy speaks to Vascular News at the 2016 VEITHsymposium about the latest data from the...
Andrew Holden: Nellix EVAS Global Forward Registry
Andrew Holden (Auckland City Hospital, Auckland, New Zealand) is one of the principal investigators of the Nellix EVAS FORWARD Global Registry. He explained to...
Bob Mitchell: Latest developments in Nellix EVAS
Speaking to Vascular News at the 2016 VEITHsymposium, Bob Mitchell (President, Endologix) discusses updated Nellix instructions for use and the potential of the endovascular...
